# Expediting Myasthenia Gravis (MG) Diagnostic Evaluation: A Novel, Proof-of-Concept for Undiagnosed, Symptomatic Patients That Uses Social Media Targeting and Self-Assessment

> **NCT06381284** · — · COMPLETED · sponsor: **ZS Associates** · enrollment: 215 (actual)

## Conditions studied

- Myasthenia Gravis
- Neuromuscular Manifestations
- Neuromuscular Diseases

## Interventions

- **BEHAVIORAL:** Social media recruitment
- **BEHAVIORAL:** Self-Assessment
- **BEHAVIORAL:** Follow-up

## Key facts

- **NCT ID:** NCT06381284
- **Lead sponsor:** ZS Associates
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-28
- **Primary completion:** 2025-03-03
- **Final completion:** 2025-03-03
- **Target enrollment:** 215 (ACTUAL)
- **Last updated:** 2025-03-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06381284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06381284, "Expediting Myasthenia Gravis (MG) Diagnostic Evaluation: A Novel, Proof-of-Concept for Undiagnosed, Symptomatic Patients That Uses Social Media Targeting and Self-Assessment". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06381284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*